{"componentChunkName":"component---node-modules-gatsby-theme-buzzing-src-gatsby-theme-blog-core-templates-post-query-js","path":"/en/hn/26690751","result":{"data":{"site":{"siteMetadata":{"title":"Hacker News 热门","author":"Hacker News","description":"用中文浏览 Hacker News 热门内容","keywords":["Hacker News","HN","Hacker News 热门","互联网热门","科技"],"siteUrl":"https://hn.buzzing.cc","telegram":"@buzzingcc","iconUrl":"https://hn.buzzing.cc/avatar.png","defaultSocialImageUrl":null,"social":[{"name":"Hacker News","url":"https://news.ycombinator.com/","external":true},{"name":"Buzzing","url":"https://www.buzzing.cc/","external":true}],"menuLinks":[{"name":"每周精选","url":"/issues","external":null}],"disqus":null,"utterances":null,"localize":[{"title":"Buzzing on Hacker News","description":"See what's buzzing on Hacker News in your native language","keywords":["Hacker News","HN","buzzing"],"locale":"en","social":{"name":null,"url":null,"external":null},"menuLinks":[{"name":"Weekly Selection","url":"/en/issues","external":null}]},{"title":"Hacker News 熱門","description":"用中文瀏覽 Hacker News 熱門內容","keywords":["Hacker News","HN","Hacker News 熱門","互聯網熱門","科技"],"locale":"zh-Hant","social":null,"menuLinks":[{"name":"每週精選","url":"/zh-Hant/issues","external":null}]},{"title":"Hacker News  人気の記事","description":"人気のHacker News記事を日本語で閲覧","keywords":["buzzing","Hacker News "],"locale":"ja","social":null,"menuLinks":[{"name":"毎週の選択","url":"/ja/issues","external":null}]}]}},"blogPost":{"id":"HnPost-26690751","excerpt":"","body":"","slug":"/hn/26690751","title":"New HIV vaccine with a 97% antibody response rate in phase I human trials","tags":["story","Hacker News"],"date":"April 04, 2021","dateISO":"2021-04-04T21:53:25.730Z","datetime":"2021-04-04 21:53","image":null,"imageAlt":null,"socialImage":null,"__typename":"SocialMediaPost","thirdPartyId":"26690751","provider":"Hacker News","url":"https://news.ycombinator.com/item?id=26690751","originalUrl":"https://www.europeanpharmaceuticalreview.com/news/141892/novel-hiv-vaccine-approach-shows-promise-in-landmark-first-in-human-trial/","imageRemote":"https://www.europeanpharmaceuticalreview.com/wp-content/uploads/HIV-Vaccine-1-scaled-e1612534046138.jpg","video":null,"channel":null,"channelUrl":null,"author":"MKais","authorUrl":"https://news.ycombinator.com/user?id=MKais","authorImage":null,"authorImageRemote":null,"authorSlug":null,"score":663,"views":null,"sharedCount":null,"likeCount":null,"sharedContent":null,"parent":{"localize":[{"title":"新型HIV疫苗I期人体试验抗体应答率达97%。","locale":"zh"},{"title":"新型HIV疫苗I期人體試驗抗體應答率達97%。","locale":"zh-Hant"},{"title":"抗体反応率97%の新規HIVワクチンをヒトでの第I相試験に投入","locale":"ja-JA"},{"title":"抗体反応率97%の新規HIVワクチンをヒトでの第I相試験に投入","locale":"ja"}]}},"previous":{"id":"HnPost-26688455","excerpt":"","slug":"/hn/26688455","title":"AMD's Zen 3 CPUs Are Susceptible to Spectre-Like Vulnerability","date":"April 04, 2021","__typename":"SocialMediaPost","provider":"Hacker News","parent":{"localize":[{"title":"AMD的Zen 3 CPU容易受到类似Spectre的漏洞影响。","locale":"zh"},{"title":"AMD的Zen 3 CPU容易受到類似Spectre的漏洞影響。","locale":"zh-Hant"},{"title":"AMDのZen 3 CPUにSpectreライクな脆弱性が存在する","locale":"ja-JA"},{"title":"AMDのZen 3 CPUにSpectreライクな脆弱性が存在する","locale":"ja"}]}},"next":{"id":"HnPost-26692144","excerpt":"","slug":"/hn/26692144","title":"Ubiquiti All but Confirms Breach Response Iniquity","__typename":"SocialMediaPost","date":"April 04, 2021","provider":"Hacker News","parent":{"localize":[{"title":"Ubiquiti全盘确认违规响应的不平等性","locale":"zh"},{"title":"Ubiquiti全盤確認違規響應的不平等性","locale":"zh-Hant"},{"title":"Ubiquiti、侵害対応を全面的に認める Iniquity","locale":"ja-JA"},{"title":"Ubiquiti、侵害対応を全面的に認める Iniquity","locale":"ja"}]}}},"pageContext":{"basePath":"/","pageType":"detail","id":"HnPost-26690751","previousId":"HnPost-26688455","nextId":"HnPost-26692144","maxWidth":1024,"siteMetadata":null,"locale":"en","hrefLang":"en-US","originalPath":"/hn/26690751","dateFormat":"MM/DD/YYYY"}},"staticQueryHashes":["1239077767","2744905544","3280999885"]}